MedPath

Dexmedetomidine versus butorphanol to prevent involuntary muscle contraction caused by etomidate

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/01/030855
Lead Sponsor
niversity College of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

ASA I/II patients

Either gender

Age between 18 and 60 years

Undergoing elective surgical procedures under general anesthesia

Exclusion Criteria

History suggestive of uncontrolled hypertension, epilepsy, bradycardia, heart blocks, heart failure, psychiatric disease, sepsis or systemic infection, neurological disease, asthma, chronic cough

History of upper respiratory infection during the 2 weeks before surgery

Allergy to dexmedetomidine/butorphanol

Those having received any analgesic or sedative within previous 24 hours

Pregnant or lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath